%PDF-1.7 % 7 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20190625113153+02'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 8 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 8 0 obj <> stream xYr6}W%Ɍ̐QIl2j_<@$D#$ԟ}Y%qN&S2x@9P!^Bz{zM!>ك3zrQlAƛϾxO ߷P;úCE,eH-z_|-ׇ_ o9 `4>.#<q>|u 4G`]w4{^_9r[yݠ;?! gdN3hбSKE(OBV IETZ[%SQ̅A_Me w Ѓ ώ&{M MK \%+gsArq*¹jƧR&aΕ0v~a ‰ ˺߅}~ "H"&"Fڠ&XA}|nE!TEeCH r[{*jNv!jok,QWvT=%)S4%>NřB͝B=ͨQ%Xod5oL~ J # TОUT)ܙ^-zk̉%;v4Ԧ]YXxJ&T:G},e[Bw^vQS_rsU %9fFQ>5)OA gq&~V?p˜'–2s4UfQA2#ԩ %%8C jz/䲎VJ6-U9[# ZnhH= =W5p_videPI./hWq&fJAdOQ~P.{A/Μb+_tDkf uG$C' endstream endobj 9 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20190625113153+02'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 10 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 6 0 R ] /PZ 1 >> endobj 10 0 obj <> stream xZnF}W v!)R'7A: "$%oc }̒dq4%TA ٙ3gfģ\{x\~^Oxy G[ޗ}~;o|ߏΊ};. zuľV`Q\|F_ʇ+5zyg'?a&?Z%4%kYfHĵIJP*>TcU L$Rk̤5]'9bM pOH~\ 0L dV 6ȋHSAb==O&d!3QH#sѠi1J#2QSQ|>U&r$pdmg!i(kd6q..8rFdEh8sXқZZ#q֍ʙNkKtgE$@H@hL:5ZUntڹQ8`"gJCl{6ixud^{Q ǃTvyeϓ1AwDIz>oA4%.\.rp ve;p\خuTQf Ίo)ih\XЯM_cMo:YYIh̡15Gχ 5GAQPɿIU,(%\"khXIsd -7g!Ţ$T.v;X\ȹ3;6͏ ̓M8 Xr2J,& Y2ں$ߩ4J/v=g} ∁ZxW0jAkii4k,w߉~.IU8!c"WFr`&'M-sy}gWQ'(zpeH'QuK?L0"g@Y<'S T]*;HIO j"KZosSPp R:9rcGmȜYDPȌ"[{D]r*U_ϰTm+jU۾A.Un둁DUT8A]vGl jP]0mIL]b9 jn#o4 DvV4DJ3kbΚnv,f#Unfsԟd4~Fs8Zi8RƗވSP;ڴcE \#w?hFL7sI?N2 ZK8#/X -Fh*TiX~7fy+mJR1U\Sψ9Į5RJNc,g}_**;$xF^ O*HĊLgIb$ZI h VjWˮ&A d*KMTɅmF]UW啦l8ڋN^I!{EKrH׍q6S9fHaaWv\Xvo)&۶"٦.+d;}wuϺapv? {`WL]QFN`ΟՕ[UJgOŸ`C1Pi endstream endobj 1 0 obj << /Type /Pages /Kids [ 7 0 R 9 0 R ] /Count 2 >> endobj 3 0 obj <> endobj 4 0 obj <> endobj 5 0 obj <> endobj 11 0 obj <> /Length 285 >> stream x1 0 '"1(;Pk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZCPk5j ZC b[ endstream endobj 12 0 obj <> /Length 30378 >> stream xԽwcIz'E3I2d2Ϫ,_]nhi%v!v[hooq8@.N$$-FvLkF㺧{ڔ*-3LgLf2j5$x~ 4?*"HA ) GJABƍ#BBB@>c!adk wƏ0"}:p.k֥Wk MId"w{s9!yomRA!Db1eٖez4-@UUt]? 90!jR9Xy}J,GC- s"u?<& 3<΅D0`v*8#v_}al9c{ecBwrTkyQ/6ϧK{eH!%EN!w]-8j׻㚥Y7MEV)/ʻ\ m5p03Ms.MS[qW\qk;$LDר㑆TCL2Bi_m !@Zf1BHh-jh (RR !%c1F)ue8iRAU,ɡa_YT {1B_3Ӵ!]jQcLrc; ιePUDAic\ G!M%ب !GscpV~};՘@o\  Pk;N4!deلTy۶mJ@ͺD,B|[uX*%/?4vZbjw\9RuDk\S{+E$I1ƕOpZܶb "k7^5BXQ!D*+ аKuzT^T}_$6WpmhsƘUU۶-rp [?26N/Bc̹0M|>]b$KD_8]u JJ TC)\l[UkFRw{zq@x8s!=u{IE!BlQTKJaTQu` qglg(ʘ靀Ɵ+jݏR"Vr'ƈŵ^ֽdV ceYmKQEsns+ x(vr< 40Hue.4̋yoqZkC kJm+{2%10Ԃd"%EQ-_`45*0&B4=9" 4!.xBxp!c̶iӬMiQJ]wRfY px:RQꜞtXF+\8wKz#G"BvG26XXU˲ Ôi2E:@`EQB#BI$[]J~/H.T\Ǎ]WHQdB $H6xBHRצk#yԄ RA Bt];> ;I6<HR=#xbj8 ]7m*ĉ*qaJ9"#W@&V;R!usAƽk&-,۶-˖Sj.HuFUϤȱl izHЫW>4MUv76BbAf'܉r0l cငHjW97h~ Z\΅\"i2%/!LIwd=\O~! A (Eۗd5j\6&K Do1FRk ^# ]J϶eU#ܽLJu9`/, ޕXَ׺J.w]75WV:Z:FY4vm^PMԶIJ1nYf3{:A#\B}r+TsuIP'p1*?8FMSBljׅ6S\ITUCLwZ"{CcP>i# u%cIG hgG6۲KRPHUUUACلW*U*r%mSkڋ{ɶmƘaZBs˶B*ns\vч;1-K:TLӧɤU STSBP/V*!U!e4mʘImCBEomϴoZd׊i"m(|ľ$d0 T+! jB]FpI*V-*Tv r/Kjn7YT^\zyDP&% d<(>.3wiߝ^\G!I]!Ѷ_)eiB~jBTMń3ͭtOO/%!$BdGK!$1I1;`'P/pMSoE2c|0cfb Ŷ`vA\`:tMw~~._enlf]UX8BӅR9ٝLB.|R6SKy?퟾?^;9>(Sk҉s7,`'aYBFVg*qh";zP;xBn7oQhYVPY\k/^~;tMY\>6<08lfH$_x|Jfc#C|X_pr̜i-$co]\;YZ]3L+}O?Ϝ9퟼gV(~գC[|0RPHh+>7޿z!HuĿ+3Pp'({W2o#Cb䑑s_qb|\,Җl82^pGFzrf'~/~eÒ.GFo>}W>8bBX^[,ۦtl܂eӡϾl,fx{j/=b NK\ҪHX;:B;Y+Nl"碙 U$;[vr~7y=}=crܯrH`ot |t03L+/ !h9uӲL ́TbZg g3B(MsB,~sBT*UW2ٜ)_XlKǷs!i[.+ YQFUPJNv%MJ?v Jg62Trq5|(ԤiY)dۡ@`g#u蚖/4UmJX[ذVw2ur|4( M%#m-mu^òшMm BgR(uӲRT"j{4Blf !@`P.L~5s7NC:@KIƐQxp/9q@e'\vMlE0FuL+(XIUUơ?^7peL[[aurI$~R7AMMzOrkjv}z]F&h<82נ4K@fH&6nVc4$o]1'z'knF'Ep RBR'BuJNpaeoHseV0}Su%se$Q{h '(lތwgH*n60] N|E{p2iNJwƫ)e@4K+<I_嶢 c\JEމ] +*E)p';^{c'tnП!KR).j[r b Q ! B$ιmSΙM42@UMqP2P5*~1ʹ$qH19v7~!I^[ nB>arGrBd$!6>' Nx-YQ[Tv'YF+HG3!5e&iVՉ]=T *6J)+yIrőD2:Ȋ<6@'v$ЯiD UUw3Fh5'@ ~ad?}ﯾJo{㭲Y[[~ލ}>%/y:5jmWO`UY͟@J.tWx5kHBoQxJ)%g_I҈V !lv@ffB0!mc0R2n+ci@BUUwъl$Չq2cBiRy B=-@]Uvvis{fmagVi~%D5X~W1U'/# >溹46%Fr TlQVx[^ko ?ʼIMVVs [V#$7@dYvctfFs!^&eYI ic5EE! Bg!y46Esj $' C֜C<ل{h_ޤ'M{ hn ds.jDH#Y*KUFQ&m3 :el#Ko[gWJU˦ҋ i(\1M2t瑝О IqW^r#L,fɘ#yrWB-~V}jhԶf'ì/GLC̮-*e%0mƣ)MQUX[D+%BH2BmW%mse{3[.?OvFJ8;58V6l].ɑ%S6T o`Nu{QG@u){1~OuMS5Mt*qW}uUo<˺0t]o|:0҉s~aO74ی[-e&‘{D8rD#ǎwFc>l?Ht>3rl5ueŨuI }Gۓ7ÀbW|:S@>3U̓#>MHEᩍW0 c0 tt{j"yzx@0ùhV7_ӓmTOE^rX25CSkqtykI0JկQTzmވ'|57ּD2)-?oа7KVKBx֧V&H_}7 _@0RsJ;Ѳe?k4Z6tns5oD*_.sK[E]X_V"M{H6KO" G:‘sc[jApn}sחν/pw[?¾Ln- ltY],$!Z+5@ 0BHrRqnƌ20L4M2JŰLbeeV5,ȩM%`)F2jJR Ci2srfHTyHZ^@\m^_<ͬK'z?|O })g!D@yyR@W&+H˲ݒuͳ1#9ciY!@NL!?ʖ@ ivjۣiZRiK:NB* ޢ74g`_1~_]:$;:\pwF@! k /B\_Q0BȸbGmEiBݕq)"TEO@6…BXa{OաټxgBԝ+wz'Gfז;"B)V*9}akack|+,#m\];?r,T%>9?rL!2vat۟ʤ/NG>rnh2xb/ld.O~OH4朿wFG[ /vF?T4~zpazӗQ$iXJgF7F;g7V5U{prp >t{`L#ەa[_<;ѶO]T 4co NOG H{"Z!(; `Q^y' 7 &QmtgVM< ug&!YRRw1ny@V#0U̯6Rk'܃}0;tks o_eVnOx@Gw>}?ѩĕ=Awԑ~sOKgp㊮pl_㙻Co| G6Jgb_&zn/5}62S2+R'۟[o_|ato}r3~7//mf>wvL߾XDݥG/?*n/mq'3^]mn]kKarev[ \(~TiItFv4>*( 8qFWw]5d~ Lp)msJڮͅ`sΙm3Tp8pe1Fe5-Sܱ1Ľq./\/KS`'QNnyLz0 èTJRa0 !cv@P5~q6lږb*8{q6H,Fx(ٵ* 2wF!d(9(f1.JvJB~4( G+*NK6˦Q4~zHEpO$~\Bae6Y]X惕xr9QbkUQt˜Y]cX-wYP*r"X~r`-,uE)' -lFA]WK1t4wzȝϟ}`Tϰtn}n4j~6R-LXj^ 㩾 3 /mۜtOUۂlH4R[ nz{ȩL{hTmdm WD@<9ISxV-|vvp\U{ˏN [[ZO v/pGõΞdz{sm;{wbәѮsgG Fefm97tE}j#]Cpܑ`2ު9jD~< rO{+` a|6O ^{8)DMY?ZOÑb2~z`>e,|߿1;e✪>UsMΞ+KsM`(bB$w]ϕ `pik:?ຢ!ŢQkz23mzޒOWԕVF2 !_C"GSw2b[_BӫKU6:F&O{T`|aZic2S1?yN\魏2+/;}u0J/vt'K}I"珹K&dN8uDBH¿gm}ܳxpgwH#pWv6K0H@w> ;݈C?Y7:^ܩjnod.N̬.B6Xo Fu_*.gyBxJU FU-YpKpk^ 蝍g S`fxoQ`T#Jzzacm:}©|9J$dW'ϙ1ST@B׿+ &2)[w /f7O LFFhT2+[&  @"  L߉"Ǻ7 e%m늢PF1Lp \ |o8r !@3~ *yq⌼gu[xixyu(i4~~Su]rpatMe]BX ɳ 814>w,X ˯O>{p~c0/yiG&z#zIH#_w<G=U5:ZTtpI>Wk-=f !,|p:|$AB|Sm e.f7dr&`|j``tdVLB8i͕ Ә^ZG'z*x^WJ/<50JlG?nZ,#|*㩾|todpHg|#iWʡP8W.=3v<ҋG <5|LUT磜qODkw<=pat@{vXԞ,{GNz B3(\L?[ !0)7؝u{P) tCȎ3W6.r91oT X y=B1T99aBE~pO%h1QQ&bݵF^Eڎ 4)/Bjϕb;VX*t&=.R9sYHoJJ*͇豑A[!lB)lfm!;:TRnRJk]8!Xf@* ).辏1V5-N2!J#.ke3uWW@.鴨֚jR{+4Kʴy^u C OxKM#/˕9gߧp.@6_HĢji.jSkkns۲iWGsYCa\ |d{b8jX*#tMph+T0n-'GDB;=DOgݙv~vq=V1My@(_*+FT;3҅eÈG#ܾ?)52 }O#"cv!n>~V֘Mc+O| tbmaôzoG ,eB@X,J:S6:εh# johPpĮu<5s7G1xgl;}JB?e4*J<IF>][]ߤV*F#N06,+/\<9iG׷E̦<&RZj6v/~yh_Rm˶}F1,)\UQ&G#BToFu]3%av0K b3i+UdbX }wgӲ1x0-ӴRأt!D0RUXtĢ aJҕ'ݴdAnvJlo;5 ;$[j]ǔQ{:Bxs['UU$:lbAb\:5ivT^^[?ydԯ=XDUa0#MUC`ow4Uhx|wm#ۓ+F{JwgRvık vvX*˦e[ۅDl|{e}sbx¡MMi[(J+ʕdcԓ]<5^:xmFtǺ;2}#UU%Ol<}jbj~)PVf (^2()%ZIvZhY4Q}mTPZơ9דiez,;@b :\|jɦTQ/鵕Pwn֍/a# !*C# UQ4][L"mafd \*xY iryzHva#I&Ɗؔ'd~vuMR_h,%Ee̩A K]-TBad乓y;TH! sYӦ@h6 #w5jD;0@TLHjV|8 e sLnW~j_Wg_Wg+- KPUUi[ɷV}q.0_l BH*jlxI4%W"h[H8|滖u`na} ʒ'79C\K !; 7 _9sGOl󯝼 8W.D<}/LY\_}3>U;?So\z'ͬyOdz8ӯ+KG'xhc/93].gO>YH}V_? GO.oJKƼ=q:W4A_%NHweۣ]}{- !"?ݥB@h4գ+S#߻~Y'6k'/W[ 3Hl8[|3> /ݕwcD4Y]>7}!MWƦms9q^ X<}D&1çG@xw%4;sZU©x͸aK牰4đU׵=<.+ ?1♢ᤂFρzLU5)rVVS߼n s>!> ΫUV1&8u EՊeCmkJ@юgƏAw{br`DQK8ݛ#4U};':p#kM=3~ܴ/}V*`텍U@ nwr@R43Ϥ7'U1 N+T4~oDOœWX+sr"LQd}E!u?J79҆7̶:gA5JV! $oVKN*7ճyDzKo1 d 5^ Z`q5#ABթDnPKADJctݢ d`6$Ŀ5bTLiPw&)O4&)V_j'=x+8F΁0F(B kXo^(N^쇌;0^N!*K7lkm{KʖdsGO_Np~O߼SC f9;Б_;oHGoFw4 zH 8YDMt.mg =Z_%_:u3/OlgJEÙ:@yáOK^{N2H`kvLolt51̲LE'O#g<'I|bUU8^uǥ2]D=Ƌs^nE{D]sGOZ.ZF_sN3K|Sk?{-Aݷݘ~mF @=Y]:=|¬ksL1E!_A7$/K YZ_^%:u!9y?Eƻ/OB}hbisMqon|8r{yRcL9WIKc$I^DUGwW;3;.gw%ЊDAҲ, `Y?؀?!aDI6tY!%{rggfg{꣪?^fTfVfVVua鮎̊{{Q[3 ʘӖ >S?z믭~ܥヷ7WE)A1qv J.3]BQJ.(RL!$n@|,{p ̝sar=DFSGKD[փ?-4ܥH.4>* ^,npBPfkcZWY8?5GA^R9Ï΍O'@RnB%fsM!EsE|o}פt|W;ߺ&3TJqN]Yt;^z}dP)ޚ8KUQd'$]BQ@^9g8ӽ!N?S)%ؖzK*F(!d4D2D)1MK#{Âsbfqu\m}$=0 _`𙢔0mQA NϭlNMXըBn.LLuhRJݵ75;o&duk7VV'5ǖi|<#{3Ӂ?፮~6vW7ڝ[+kO^X}ʥݿz%2c[FR1…t]rockucut|~i6 ųK[;3VږWfS ӿI<8;lQB.NO2Ff-Noq.(%L:z G|? !G %0w~nOls$h J#9ٿRzr踬dfK < yJ!~ 1.fF@A"zD.Vm{l0y(5b%F 9ud'T*NP]7[0%r(7xXJ<Ř<@Q !C3!삭iF%`S2cCk9aΝS&.%x\0FG&ץݸ/Wߘٽ>9AM)}ƻnlRyݻ7]jwfsg_{rv~Ҽac߸:l_V*~uRyq7~j]^2 cuckwoy~X?8xd e/];S$QӉ#C?0+(BHV0&ڴS@c?l!sgf19>0;?tg&tŶT4mYGvZ'&,Өת<~ѱdL6cϝP,s!'-|DZ\{ug|C 7^~yxs.ZU*dyanqfrvij`4Vq>qQ?ڝc͖yBʀxbTG!4NcS(BHȄYJ]VR*:H+qE}+U7Y0ċ"vog/ Nv:r[@aIb1>zqcQ3V(a]w^Jc.rÊB::6JRqt]O1=8lwj `Gtcl5MӘiL4(cRAZRض4L&ۇdzSze5 f'' .aSdJ*qK^FBrWeQ~#xfgTa,"||qJ2ovjLèW+RDx]7Z1PJYJcK)-)رlc[tc3-!H1^oDWBFU@) л0L)CPg"0셃g2 !6S+Ig]OP6g9 MR"pJ0W&! p!h &U 8}aD4hr:ר=xO )iayп)G0ڴ=(F[jJ!ceYrq0AtUJ B,H$M?)l/Ĉ1E<aB%:r.*:V4IOBax`Jʊ+3Yg !1*fYaQ[΍ UӕiR*?ޢ70=JAxVDx A`|t̢jB}MD7Q@ƓDU˅HBG4-JE>9; )9 C9IkT~/OzO-#өpxZfz`RJYu)$U𸥕PN]Rш2i/0a~F]n=K+K:iS*>FC)#8a,MEJ) Թ #|1 ҔpWג24-r䃧J4N7җME*)1FyeP,8r'KeCQpuXb"D)ci[4!do<HJ{¹5Wp_~kX̙j\ܓ?2sn8Tfֱ~ҥhgHEKP&(NU> E &`=T ǩnM'7P Q[`Y_,z9KN)y~*OGX0Lx?ξ־vΘz Q@Z[/n/>?}^g比t)= M> $0d14S׸X-2X!Q[59YN|},K^pcaAh{<,RV#bW |cK0,#b˝]~=Co[/+w#瞥%gL@Pۈb(rBji=qYT1l05VVLJYbˇ6|'a(dD.cD2Omdh~R켒R _}gsg}3 ~/Jܸ$F' _JC?2 nO5XW|u7+5bV wAjSؿ}ʂ72 `Lz`G! K0lja!&xɔ+~ c?R`~0%f-5Zx5pxPd)YV4͖g:Ұ!;*!g1ryfTXtaKy84TXԨJQR2B' `X/1hqKDQ3w@HZR^_?ZiB_A14ϐsO|ߜxFju l( Ψ=a#Km[8cVAŒ$*a %.;=D8|/HqSӂ:1 wyψND{ E&z1ͪ@TXv+΄3s6ՊnI(2'D DASb99]#[uBJg]UQ6-G(U j߻wo٩psƮ(0 x &qRy롿Y@ ) Tfܱ4IJyeYc&"0F1^8A VJCY}~ dB 0pxE$RŠRJ0ߗ4,lUDD!O=M!ϙ9Y:02(FEŧ s"4V' O^kR^nSvoJBTYuq z9ݛԤI ZZxp$al*^JΪb0 uBH,Yqڮϥ";{w(W{:LJ\ʈDofY~JI&;:N5*.!3(^[!Ud(:},czPxr3  .dl%P*7\Flj'bmbZֈD;AǗVيm2J@*nxBYd?b*@9f[(|2%C+uRed=8]m<7ҀBL}߷XVJۄ&жXF}JYVLȄg01epeA\#Y=cΘcly> ';3ڡ.~`*0]x>$ej0A ,KXEd!qPv`s/y⋤+Jd]|/Z {`>c>^q.Ebu= +1^(~*! &.fƘ85 dvzanp=ƒ7_|m7(|sk-zjw rq!Fm[QqCrR lB#F&UBqj~olJrWk=E,F5CzF)2kʷZjH92uϔ[6n*GK7).i8ߍ9ݮQ3Mq,Cb=2; /77O>Wp-/rV@h^;7 sEi۶8٫'4D;\8 jO8 <_`4qD427J6~P="f8CRfz#ضUgP8:Mu}LdnŐQ Z!S 0X)~VazT*Vo޳ ڸ1g-ҕRpAo9?Oe&x)O$᧊ Pj2DUcD78hg)VǕ+BۛuO2t_{ ԥRFSZOùn*(j$It܌v/<} G lKr#v[q-@ ^Szfis_.UʂQ1^IDN;nO\#tkT7JV0JF`L`PJy7.A׿AZIK͎@K"Y"B'r>op=C@HPpr&;juclFyoTe?TJJ2ԓiZRZ`dɱ-7۶t9f$,+%8.!u=q A @,L>RJp90$1qr qL?V`un6x>RVwMoO>'`QN1"[PGwno{0^X88ޘQ.h!D AI !Sڈ7>Q[ Hj ۜ=q"A=~-INb0 !$2p2U?v.MWM$߯LF=3{38(x !@ 8E7[Y℠c;)()Uy"OhVwR %% Rb9¸ȟi6PT29Ie MҊRJ{jL"Kb Z/镻;[]{W[&B2Jn+PQScʾǯl3Kvpg8SJ…:pP&#US*.&k=N:\F$Q׳b$//WZI)9`œafBy"L.<5FAJyZYII +6žW =\>b &3P :;fW^zuXu,(W6NcqU];uY߼ Wn[P*fUk͖ᥱo]'I%!4z8@)#!j R4X6mDiU)^ ^![HMgS/Ǚ!"#>.Y&Kt K&X8Nu m]~f˶Ƿ=_Hd{t I +-oyabaLmvon{}ځ˅ t}=wh䀔 rPAŏpX C^.ac KνSKݠk5`|byL\b./];7Õo Bwf>Yi#&ڞp~ΧVl\"Aaʒ#I*Ҏs9ޫצ[&EV=4P(% :Od*adCm1 Uea }'$x@GSCҼSO]JٸUJfK]2bXe:vʝىǖj]wX;I) o֏婓 JU*@I*X|x\)xӯ$d4vE7ŦLAԾ(Cs2]7պE>"yaaCQ>tQBHtw3@zhחKI?-37z* 0d>רޚcVצhis\MCrtj́Ldx@jL 1abh&u-.;JO;djLW-^ړf3znMZ0@xSXD`` #5B,G5(xĊs#G"џ [)Di#xed5 0i@c@+wh'ԥ(&7\2v]ʰ< # G)UPTJ@D#s7d4˧bG_sOx_$me4*,#/u]]h\yO/!@ 7G"e E*ן. Ϙ2.Nl& /W<]!ai#g)eyv~&eT8B),KJ]>^Ƣӗ"O ('ɚ .u)6 WjW/95vwJV Q0%L6#=p('˪R>A*GR0wyʜA @Aϖ{8=SyJַͽd]ʻ]jTJ9%*CӨ J xp3s0xX>!0ur0TWJƢ U6&=‚[P 5ԡR) œ,C_a= ѐȴR>QqbdRr,+7Xr < AQJ)!A'` H1WLj>":G6GHRCG0Pa b"]5 y endstream endobj 13 0 obj <> /Resources <> /Font <> /ExtGState <> /ProcSet [/PDF /Text /ImageB /ImageC /ImageI ] >> /Filter /FlateDecode /Length 848 >> stream xWmO0^c$H (똆AIC|J(ՠemIªل׹Gdw7>9<GkDžaW$<"H2|R(29:9$^-e>..y.Gd:|VCd` ')ɮB(TEҒ %% E֙ J,$BDO&D>MH0-6=C.h&CfR\ X+b :Nic*k+ p.}&xs|"8 n,v )W-6o=߸hNftK:M[ۀr!e\KeAky$RP<⺍pxup8>H  M{qI3_w,縲eGfNՑmna.hȓjYU,b\2OuyZ6#sC͚3gkriӲ ly#4]kDfu |w*lm O镸080iIsӵһ%7/i\XJ.̚5K5jM9aq'wqh%Q*i gyQ(p]5'CԫkSuRCln_*9{.+|FAqp-Pg*O hsRՎSJ&`1U$GBHB-K5NюG~?Rh#%SkC3a-r"7αը $O+ o endstream endobj 20 0 obj <> /Resources <> /Font <> /ProcSet [/PDF /Text /ImageB /ImageC /ImageI ] >> /Filter /FlateDecode /Length 220 >> stream x]M0EԅIтUqEڅ̿7.:Ãۼ{?bb_"YiFgTT&IF |Sk=(PB{U!Z]?s{7mCwoTbV DH)iRHK 4 A&J0;*UaVj&T]Y-v|OɄzUx5>w I endstream endobj 19 0 obj <> endobj 18 0 obj <> endobj 25 0 obj [250 0 0 0 0 0 0 0 0 0 0 564 0 333 250 0 500 500 500 500 500 0 500 500 500 500 0 0 0 0 0 0 921 0 0 0 722 611 556 722 722 0 0 0 0 889 0 0 556 0 667 556 0 0 0 0 0 0 611 0 0 0 0 0 0 444 500 444 500 444 0 0 500 278 0 500 278 778 500 500 500 0 333 389 278 500 500 722 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 ] endobj 24 0 obj <> endobj 17 0 obj <> stream x  Om7^ Oa endstream endobj 26 0 obj <> stream x nH@o endstream endobj 16 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( m{HV*ڝ 2֍sD$;k]-j** jmZކ6PϷXkW״y,H$c``qW_Wx4pYd]pI"TnϿD1Vn57N]KEgi70n63# :*Zޡyڬ4:Гp vFJ{m龖u_!Fxgnz犯6cjP <,08 - bE^Z7wmfON4%pJ<H%f\OnMowC۾ǽG6<_jx0&s7kvߙokVkY~nn䲺k[X0eXuV ~ILA+G#I(D8qc=>J'}77h/Uknmkkb 0yHw/6@2nY*pMzU3%ėڌʻe/9I>OS_zwqlTM$1!vzڥʺy22eg{/㱷EgX\?lJ8cU4I #|K3G|T{ƿZZunTpCp*H1S0I\։r,f ěsR>hJq:Z+ -kP[ '̀ 8B޻F9fB<8D>hݴ5NDn+E說uZk6(95Gyd , 9kVh驖cdex[O!U'}me}SZwТ5;hMΌR ϲp"5iOW|LS d {u*mMow4Z4baIXcnf>L«hIc}h4lHg'R*uٽ~ocVʳէ{~`HdS!r+3Cm{TWx24VgQccm{u"=ŰNy'&U Eٻ~-lNr֨WIѥ;W>z+YT3*RWi4׫8ȗĚ̐Zrо ~EO XOԒM]mllͭ[#l%IMIikV"v''EPG9@``n^s _vbWe[3ImjK}\iY >}Ac1GI]VkזׂMKsn!rK2@ێ=xku{MJ8EDR.v)_KIkz>M +mv_k2sRj#$d>Zl;5i!)70 :^v?Rnm{ZnkYWzXiqVj a idzI cK>n[}鹭Eb6q6wXy۰Mqjk Vy4Qotdtf߯QRSmZmB;iI $l3gVf]&k|QlaB$&pL#oN55&!b+rVvپz]ڽivI:@$Yv&F'>m͵ 3D[pe=OqIњWȨi\iQX"v:k"H)2Hb9$rN3[3(;HUY^љ] ʇ O|k%ՐVfrkzxшLn\]:Jq|JǶkRwooYRm,ѵӱYWz\bIYؑ'}(n^EEDzM"5u}f7/vkX$*8!YbEi" H򤌌3\'m9CqqJֲ: @KgɜL*A}gK$խS/+mEaEjw -ӬfY< ~5$!?ɫG 0xXemH=y*^KFW+]WA Xrڨktk@¼eeی;g5O]M絷ZD2m1|prQ}]DTӌ%%{{Ym(eB$18 d>i:v N2FGҥQ_r劥z/=4\ې&8Nx8Ts~V=Z X'g"YVwqw6q#$ӄ#%0U8KHi$7WSЩȧU ZhQRYv~RiS ((((m6d պᅾ[UM#zͽЬon>$78ǝ6#܎k G^5ZsUZzYjrik$XrIj[)R?}馕mm43|\ ێgH{ JqӗFk[]-4Iq)J,iAD['ciHF:VZ<Li>sBz'}֤pK{ ۩3B<EŜR*>H?J̩ay'rXP 's29cM.+j)CE*B VgY\fY.z e(FjW%# tΜYZs>߱IgԵkm."ٖ7qy$lgzun>%u?JjI&:LԖ:=: $qi =ңBm N[Wߦ~E=t>?Q7H,ඞh.4$䁏CYzT6O'$cuW3~V,ZSQ+͓&#.mjDL$hqQ (I_ZnSGMHᷓE2X\m3 vWF4 0[c,=֧mt- Yy5B TaIۖ6׽yEU Zb}?nTvpXbR]I䜚59.NJ0{rvZ5Oyu wmm<=XγfUıLoeDIp9'$ ~bvh`^Q\n3j:Ykd$h"0x侖ad̛Fߘ`Zzٻ<v,=:E: !a,,]ds9j4Vvc,=iJ[J[e_M\vAjϚ9%>- KwJܗGQ[JnLr2@ 7\ӊ^).P{sIavzƕi-vtأO k-od@_rpGo?Kb{#vDbz?[}&M37 i<$t9׭ZAIK=TZוOVe;l?ʹ^?*J`EKifXҪkOՉʭ2_7o+a})!7&t2U=>-[E5w<7QGcVz=iX:i t'ҫ/rY.+ 1ӌө7oLε |$m[׺h&$wX6+ $tVN{w 5HaҭW;嶇ly (((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((( endstream endobj 15 0 obj <> stream x  Om783  endstream endobj 27 0 obj <> stream x nH@paX endstream endobj 14 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222bb" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( *kZ= )՘W5mZx?sS)(rbzz.-+E_|dF>g?qZP ]3N'K:?ƸT/.\$s1c 'j9W᭏=Mrķsݓ@aGrZ}{R}NՋHf?^d!,.@#VnZ)BJPG i6ב9O?0H\kǝףG1>X;} ExM_@eZ}H2Bo_U a1Jr˺-aUL cZݫ L7YSG/k?oo\jSѫV]֙宙>bx.2)YWN/XޑxVRr{W\֡p~Z7gS憌#ˌ5JOkT{Y$9$5b'JAI a}%hT(((kH0zVBEY[RI(GJ?zӉ[?kFniE?D;o l_DP^Xž "Lh?g |{עW|mIW̗ɏL,WQCz-Wv\@He@єRWWTV.⤂( ( ( ( ( ( ( ( ( ( ( ( ( ziSs('*:e>#j\!eG9_Ɍ-/S#N_GxA'4?2+><(niv%Lp?aG2_Iѽ~kNe>XՂ (((((F`Y I=c9ũՍ0}E $=M ||?hjz#59½OC+oEQEQEQEQEQEQEQEQEQEQEQEQEW;65(jnm;<>/sW~ʯT4bXZJy UEYk (;QEIaEPEPYֳmX5,x0yvmwĶZDH[>X>Uծ{ƹ|EQPz^*ϚzG<\7.7y^V/ԯe}Hr}~SZs;p } J*:ӟ4lNHcfF q*<%s] o,z'eд ( ( ( ( ( ( ( ( ( ( ( ( ( +h[TělOSa )CV &8ş#im ҺkIT׆>+)lݶ~^ s_QJT~΢7ȩk>l]GȮϟekYx^=+Spߊ\5l5*F\u|+)[˧{%{|=?Z5o^݆1i~r?5Q]r4ڻUfԜ?t=*ߔ<3cVoĒkN_Wr>ʍ?g+P(((((((((((((߄a~*^Ù-e?އ?_5/e(H+ωOMUM^%t ;{cb3 cuV`k8 s\j=KtquV s^d|':d4sYP:մg:M訄y+E3Q@rLPw܁ޕ#Iifu˫梹k j%#a[a{vX5 <]/.Ѱ(vO},: q̧0cw>g`p IQ^QQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@g..-55\%ʯwG^ Yٵ;V's[ӭ}]U-5;Gr`:'KG9k!W]򥾣Z1_k|CJ}9[ϗo?לj^n4學W/#{l[%вEK]Ha*AsΖQ^ZNƿsҎq,: oY杦sZ/~u2IO~?.e_XsX?k*?2G}%pƹ&=K!..;QGonZ/ i4(|<կ'Ov/`OW (((((((((((((((<2"V`)\>|v08 Z( ( ( +7YcSFڇc65Mťvnɕ/4;P+_Nc,b=MNQى/ts)QПkRú.A,`aѣE?MD : nލPcϢ5-AAEPExK֧O`-a9?iKa9$osN(0(((((((((((z+qBԃTs\q [3kG|?wwXEu2դB)Mj὜6R~j6dTFLr@ bWW9]،EJxYۡÇNxxt8+z$oR>V>VNj|=i1}j$|$|t7WDx%y"E:9/ \ PI4A({U~ Z;u՛!/+s%K1 @A#k>X;CUB]TU88s-wrpq~j ;ƻnŧ H\4`N΀XzYTs)ՔtI)bH5K ,RFQ2l{&o~,fl;|Aj~)XeزE PsʁV<mw[iOl#dP ޠnNsZBp7i}pI$Js6qnD1ykZ<:ڹcԓ'T&*mNYQT18J^)jkoEe [xZfm,Y@Ԍ m:/Ŧ<.مP;zV?~6ݶy ޹U9B&TeOI껛V 4jTFN `Ӯr+GP%_VFBI( Z|%]Z-C;bn8 GB+v-A𦩨뗷r2z8JrSV۶2ԋ$~д}14Ni^#K! D, O@NzWH%Kkw* B2O%{w?ABӯ{i Ȇ(@3d凄\ݕLqz>-6y jp>?|aP>?9j? C|XehmQ (8C\F|µ 'kt♜k OkhS bSyp0Y[\!<yj3EqO $R(du9 Ba"։.co2g夑8?s׍ëw17Ṿ; Q\:}$_;{=SOGXUp\*%7?g۰sy9yF hYj ۙrT𮓩hRi_b8cpiZ\U4JmEp_ u+ Kor'8LI1]aV7ڕER kQEQEQEQEQEQEQEQEQEUMVO+G?)V覝Տ#m  hVZTo ?ٮX>94 iW1bOy'yEt Tu9u 6un/ ?FrDeQ`~xk^ \v-kG"NZퟝLWQJ8:nאU쒷y^d)Ze1ijd`u?zYC/&wnF1ֽrj5ǚM᫏"lB֪$9YK=2 *ޑ"lb4J-V%)lXÌ޽Onkӄgc$KymhfkuRn3[KjIoXԱ?^WUE%^ܖ_ N%c˼]!-ge2X0EzMImnCDd{ EMJQV—$/U) %qm"HAg{_ĈUڊJ 5%r6]5a)4$UM9 ៥kMxWubh0?,~:~5TVZӎ3ZK[_|AYk%ڬA OL~|5YP1cBgz 3s)+n ?+'ʟٞmc ,\ӱ3@{ d+ːJёé=qz:)iE-WQf y`JE;!4c ~c[L?= $v$7>#^&Yk%X,O$U > endobj 29 0 obj [250 ] endobj 28 0 obj <> endobj 22 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( m{HV*ڝ 2֍sD$;k]-j** jmZކ6PϷXkW״y,H$c``qW_Wx4pYd]pI"TnϿD1Vn57N]KEgi70n63# :*Zޡyڬ4:Гp vFJ{m龖u_!Fxgnz犯6cjP <,08 - bE^Z7wmfON4%pJ<H%f\OnMowC۾ǽG6<_jx0&s7kvߙokVkY~nn䲺k[X0eXuV ~ILA+G#I(D8qc=>J'}77h/Uknmkkb 0yHw/6@2nY*pMzU3%ėڌʻe/9I>OS_zwqlTM$1!vzڥʺy22eg{/㱷EgX\?lJ8cU4I #|K3G|T{ƿZZunTpCp*H1S0I\։r,f ěsR>hJq:Z+ -kP[ '̀ 8B޻F9fB<8D>hݴ5NDn+E說uZk6(95Gyd , 9kVh驖cdex[O!U'}me}SZwТ5;hMΌR ϲp"5iOW|LS d {u*mMow4Z4baIXcnf>L«hIc}h4lHg'R*uٽ~ocVʳէ{~`HdS!r+3Cm{TWx24VgQccm{u"=ŰNy'&U Eٻ~-lNr֨WIѥ;W>z+YT3*RWi4׫8ȗĚ̐Zrо ~EO XOԒM]mllͭ[#l%IMIikV"v''EPG9@``n^s _vbWe[3ImjK}\iY >}Ac1GI]VkזׂMKsn!rK2@ێ=xku{MJ8EDR.v)_KIkz>M +mv_k2sRj#$d>Zl;5i!)70 :^v?Rnm{ZnkYWzXiqVj a idzI cK>n[}鹭Eb6q6wXy۰Mqjk Vy4Qotdtf߯QRSmZmB;iI $l3gVf]&k|QlaB$&pL#oN55&!b+rVvپz]ڽivI:@$Yv&F'>m͵ 3D[pe=OqIњWȨi\iQX"v:k"H)2Hb9$rN3[3(;HUY^љ] ʇ O|k%ՐVfrkzxшLn\]:Jq|JǶkRwooYRm,ѵӱYWz\bIYؑ'}(n^EEDzM"5u}f7/vkX$*8!YbEi" H򤌌3\'m9CqqJֲ: @KgɜL*A}gK$խS/+mEaEjw -ӬfY< ~5$!?ɫG 0xXemH=y*^KFW+]WA Xrڨktk@¼eeی;g5O]M絷ZD2m1|prQ}]DTӌ%%{{Ym(eB$18 d>i:v N2FGҥQ_r劥z/=4\ې&8Nx8Ts~V=Z X'g"YVwqw6q#$ӄ#%0U8KHi$7WSЩȧU ZhQRYv~RiS ((((m6d պᅾ[UM#zͽЬon>$78ǝ6#܎k G^5ZsUZzYjrik$XrIj[)R?}馕mm43|\ ێgH{ JqӗFk[]-4Iq)J,iAD['ciHF:VZ<Li>sBz'}֤pK{ ۩3B<EŜR*>H?J̩ay'rXP 's29cM.+j)CE*B VgY\fY.z e(FjW%# tΜYZs>߱IgԵkm."ٖ7qy$lgzun>%u?JjI&:LԖ:=: $qi =ңBm N[Wߦ~E=t>?Q7H,ඞh.4$䁏CYzT6O'$cuW3~V,ZSQ+͓&#.mjDL$hqQ (I_ZnSGMHᷓE2X\m3 vWF4 0[c,=֧mt- Yy5B TaIۖ6׽yEU Zb}?nTvpXbR]I䜚59.NJ0{rvZ5Oyu wmm<=XγfUıLoeDIp9'$ ~bvh`^Q\n3j:Ykd$h"0x侖ad̛Fߘ`Zzٻ<v,=:E: !a,,]ds9j4Vvc,=iJ[J[e_M\vAjϚ9%>- KwJܗGQ[JnLr2@ 7\ӊ^).P{sIavzƕi-vtأO k-od@_rpGo?Kb{#vDbz?[}&M37 i<$t9׭ZAIK=TZוOVe;l?ʹ^?*J`EKifXҪkOՉʭ2_7o+a})!7&t2U=>-[E5w<7QGcVz=iX:i t'ҫ/rY.+ 1ӌө7oLε |$m[׺h&$wX6+ $tVN{w 5HaҭW;嶇ly (((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((( endstream endobj 21 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222bb" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( *kZ= )՘W5mZx?sS)(rbzz.-+E_|dF>g?qZP ]3N'K:?ƸT/.\$s1c 'j9W᭏=Mrķsݓ@aGrZ}{R}NՋHf?^d!,.@#VnZ)BJPG i6ב9O?0H\kǝףG1>X;} ExM_@eZ}H2Bo_U a1Jr˺-aUL cZݫ L7YSG/k?oo\jSѫV]֙宙>bx.2)YWN/XޑxVRr{W\֡p~Z7gS憌#ˌ5JOkT{Y$9$5b'JAI a}%hT(((kH0zVBEY[RI(GJ?zӉ[?kFniE?D;o l_DP^Xž "Lh?g |{עW|mIW̗ɏL,WQCz-Wv\@He@єRWWTV.⤂( ( ( ( ( ( ( ( ( ( ( ( ( ziSs('*:e>#j\!eG9_Ɍ-/S#N_GxA'4?2+><(niv%Lp?aG2_Iѽ~kNe>XՂ (((((F`Y I=c9ũՍ0}E $=M ||?hjz#59½OC+oEQEQEQEQEQEQEQEQEQEQEQEQEW;65(jnm;<>/sW~ʯT4bXZJy UEYk (;QEIaEPEPYֳmX5,x0yvmwĶZDH[>X>Uծ{ƹ|EQPz^*ϚzG<\7.7y^V/ԯe}Hr}~SZs;p } J*:ӟ4lNHcfF q*<%s] o,z'eд ( ( ( ( ( ( ( ( ( ( ( ( ( +h[TělOSa )CV &8ş#im ҺkIT׆>+)lݶ~^ s_QJT~΢7ȩk>l]GȮϟekYx^=+Spߊ\5l5*F\u|+)[˧{%{|=?Z5o^݆1i~r?5Q]r4ڻUfԜ?t=*ߔ<3cVoĒkN_Wr>ʍ?g+P(((((((((((((߄a~*^Ù-e?އ?_5/e(H+ωOMUM^%t ;{cb3 cuV`k8 s\j=KtquV s^d|':d4sYP:մg:M訄y+E3Q@rLPw܁ޕ#Iifu˫梹k j%#a[a{vX5 <]/.Ѱ(vO},: q̧0cw>g`p IQ^QQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@g..-55\%ʯwG^ Yٵ;V's[ӭ}]U-5;Gr`:'KG9k!W]򥾣Z1_k|CJ}9[ϗo?לj^n4學W/#{l[%вEK]Ha*AsΖQ^ZNƿsҎq,: oY杦sZ/~u2IO~?.e_XsX?k*?2G}%pƹ&=K!..;QGonZ/ i4(|<կ'Ov/`OW (((((((((((((((<2"V`)\>|v08 Z( ( ( +7YcSFڇc65Mťvnɕ/4;P+_Nc,b=MNQى/ts)QПkRú.A,`aѣE?MD : nލPcϢ5-AAEPExK֧O`-a9?iKa9$osN(0(((((((((((z+qBԃTs\q [3kG|?wwXEu2դB)Mj὜6R~j6dTFLr@ bWW9]،EJxYۡÇNxxt8+z$oR>V>VNj|=i1}j$|$|t7WDx%y"E:9/ \ PI4A({U~ Z;u՛!/+s%K1 @A#k>X;CUB]TU88s-wrpq~j ;ƻnŧ H\4`N΀XzYTs)ՔtI)bH5K ,RFQ2l{&o~,fl;|Aj~)XeزE PsʁV<mw[iOl#dP ޠnNsZBp7i}pI$Js6qnD1ykZ<:ڹcԓ'T&*mNYQT18J^)jkoEe [xZfm,Y@Ԍ m:/Ŧ<.مP;zV?~6ݶy ޹U9B&TeOI껛V 4jTFN `Ӯr+GP%_VFBI( Z|%]Z-C;bn8 GB+v-A𦩨뗷r2z8JrSV۶2ԋ$~д}14Ni^#K! D, O@NzWH%Kkw* B2O%{w?ABӯ{i Ȇ(@3d凄\ݕLqz>-6y jp>?|aP>?9j? C|XehmQ (8C\F|µ 'kt♜k OkhS bSyp0Y[\!<yj3EqO $R(du9 Ba"։.co2g夑8?s׍ëw17Ṿ; Q\:}$_;{=SOGXUp\*%7?g۰sy9yF hYj ۙrT𮓩hRi_b8cpiZ\U4JmEp_ u+ Kor'8LI1]aV7ڕER kQEQEQEQEQEQEQEQEQEUMVO+G?)V覝Տ#m  hVZTo ?ٮX>94 iW1bOy'yEt Tu9u 6un/ ?FrDeQ`~xk^ \v-kG"NZퟝLWQJ8:nאU쒷y^d)Ze1ijd`u?zYC/&wnF1ֽrj5ǚM᫏"lB֪$9YK=2 *ޑ"lb4J-V%)lXÌ޽Onkӄgc$KymhfkuRn3[KjIoXԱ?^WUE%^ܖ_ N%c˼]!-ge2X0EzMImnCDd{ EMJQV—$/U) %qm"HAg{_ĈUڊJ 5%r6]5a)4$UM9 ៥kMxWubh0?,~:~5TVZӎ3ZK[_|AYk%ڬA OL~|5YP1cBgz 3s)+n ?+'ʟٞmc ,\ӱ3@{ d+ːJёé=qz:)iE-WQf y`JE;!4c ~c[L?= $v$7>#^&Yk%X,O$U > /XObject << /I0 11 0 R /I1 12 0 R/TPL0 13 0 R /TPL1 20 0 R >> >> endobj 6 0 obj <> /H /I>> endobj 30 0 obj << /Title (Congresso SIC 2018. Primi dati di real life sull utilizzo di edoxaban dal Registro ETNA-AF, In Italia rispetto all Europa i pazienti arruolati sono pi anziani e pi fragili) /Author (Daiichi Sankyo) /Subject (Congresso SIC 2018. Primi dati di real life sull utilizzo di edoxaban dal Registro ETNA-AF, In Italia rispetto all Europa i pazienti arruolati sono pi anziani e pi fragili) /Creator (TCPDF) /Producer (TCPDF 6.2.26 \(http://www.tcpdf.org\)) /CreationDate (D:20190625113153+02'00') /ModDate (D:20190625113153+02'00') /Trapped /False >> endobj 31 0 obj << /Type /Metadata /Subtype /XML /Length 4601 >> stream application/pdf Congresso SIC 2018. Primi dati di real life sull’utilizzo di edoxaban dal Registro ETNA-AF, In Italia rispetto all’Europa i pazienti arruolati sono più anziani e più fragili Daiichi Sankyo Congresso SIC 2018. Primi dati di real life sull’utilizzo di edoxaban dal Registro ETNA-AF, In Italia rispetto all’Europa i pazienti arruolati sono più anziani e più fragili 2019-06-25T11:31:53+02:00 TCPDF 2019-06-25T11:31:53+02:00 2019-06-25T11:31:53+02:00 TCPDF 6.2.26 (http://www.tcpdf.org) uuid:a28779a2-26dc-cd6a-eacb-e6376f4a8387 uuid:a28779a2-26dc-cd6a-eacb-e6376f4a8387 http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 32 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [7 0 R /FitH null] /Metadata 31 0 R >> endobj xref 0 33 0000000000 65535 f 0000004259 00000 n 0000072639 00000 n 0000004324 00000 n 0000004430 00000 n 0000004541 00000 n 0000072811 00000 n 0000000015 00000 n 0000000465 00000 n 0000001911 00000 n 0000002380 00000 n 0000004655 00000 n 0000005186 00000 n 0000035825 00000 n 0000047509 00000 n 0000046716 00000 n 0000039046 00000 n 0000038486 00000 n 0000037633 00000 n 0000037577 00000 n 0000037045 00000 n 0000064139 00000 n 0000056469 00000 n 0000056009 00000 n 0000038234 00000 n 0000037819 00000 n 0000038793 00000 n 0000047197 00000 n 0000056217 00000 n 0000056194 00000 n 0000073027 00000 n 0000074010 00000 n 0000078694 00000 n trailer << /Size 33 /Root 32 0 R /Info 30 0 R /ID [ ] >> startxref 78903 %%EOF

Congresso SIC 2018. Primi dati di real life sull’utilizzo di edoxaban dal Registro ETNA-AF, In Italia rispetto all’Europa i pazienti arruolati sono più anziani e più fragili

Presentati al congresso SIC 2018 i dati al basale dei pazienti italiani arruolati nel registro post-autorizzativo ETNA-AF Europe per valutare l’anticoagulante orale diretto Lixiana® su un 13.980 pazienti distribuiti in 10 Paesi UE. Contributo importante dell’Italia con 3.541 pazienti in 192 centri coinvolti.

Roma 17 dicembre 2018 - Al 79 ° Congresso della Società Italiana di Cardiologia di Roma, Daiichi Sankyo ha presentato i dati al basale relativi ai pazienti arruolati in Italia nell'ETNA AF, un registro europeo prospettico, multicentrico, osservazionale, post-autorizzativo disegnato per valutare sicurezza, efficacia e aderenza di edoxaban (Lixiana®) in monosomministrazione giornaliera in pazienti con fibrillazione atriale non valvolare (FANV) nella pratica clinica quotidiana.

Il programma globale ETNA-AF combina le informazioni provenienti da tre registri real life, condotti in Asia orientale, Giappone ed Europa, che sono stati disegnati per osservare la pratica clinica locale, che saranno poi integrati in un unico database. Nel nostro continente, il registro prende il nome di ETNA-AF Europe e prevede il follow- up di 4 anni di 13.980 pazienti arruolati in Austria, Belgio, Germania, Irlanda, Olanda, Portogallo, Spagna, Svizzera, Inghilterra e Italia.

"Il registro real-life ETNA-AF Europe integrerà i dati dello studio di fase III ENGAGE-AF TIMI 48 sul quale si basa l'autorizzazione dell'EMA all'uso di edoxaban per la prevenzione dell'ictus nei pazienti con Fibrillazione Atriale, in un setting di pazienti non selezionati come nello studio Registrativo - ha spiegato il prof. Raffaele De Caterina, Professore Ordinario di Cardiologia, Università degli Studi di Pisa, che durante il simposio ha presentato le caratteristiche dei pazienti arruolati in Italia rispetto a quelli del resto d'Europa. Il valore di questo studio è dato anche dal suo disegno prospettico che prevede l'aggiudicazione centrale degli eventi, e dalla durata del follow up di 4 anni".

In Italia, rispetto al resto di Europa, è stata arruolata una percentuale più alta di pazienti anziani (età media 75 anni in Italia vs 73 anni in Europa), di sesso femminile (rispettivamente 46,4% vs 42,1%), con un peso corporeo inferiore, nonché con una maggiore incidenza di ipertensione (80,7% in Italia vs 75,4% in Europa), e di insufficienza renale (41,9% vs 21,5%); questo potrebbe aver contribuito ad un utilizzo maggiore della dose ridotta di edoxaban 30 mg (rispettivamente 31,5% vs 20,4%).

"I centri italiani hanno svolto un ruolo rilevante in questo registro europeo, contribuendo con oltre 3500 pazienti arruolati e rappresentando il 26% del totale, secondo paese europeo dopo la Germania, considerando il numero di pazienti anziani e con maggiori comorbidità arruolati rispetto al resto d'Europa - ha spiegato Fabio Romeo, Medical Director Daiichi Sankyo Italia. Sarà interessante valutare gli outcomes, che siamo confidenti possano confermare il favorevole profilo di efficacia e sicurezza già evidenziato da edoxaban nello studio registrativo ENGAGE AF".

L'obiettivo primario dello studio ETNA-AF-Europe è quello di raccogliere dati real life sulla sicurezza di edoxaban riguardo gli eventi emorragici, inclusi emorragie intracraniche, eventi avversi correlati all'uso del farmaco, e la mortalità per qualunque causa. Gli obiettivi secondari dello studio, infine, includono la valutazione degli effetti di LIXIANA® su eventi clinici rilevanti quali ictus, eventi embolici sistemici, eventi cardiovascolari maggiori e ospedalizzazione a seguito di problemi cardiovascolari.